BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10718420)

  • 1. Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients.
    Ford LC; Sulprizio SL; Rasgon BM
    Laryngoscope; 2000 Mar; 110(3 Pt 1):362-7. PubMed ID: 10718420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoiding perils and pitfalls in velocardiofacial syndrome: an otolaryngologist's perspective.
    Cable BB; Mair EA
    Ear Nose Throat J; 2003 Jan; 82(1):56-60. PubMed ID: 12610907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome.
    Oh AK; Workman LA; Wong GB
    Cleft Palate Craniofac J; 2007 Jan; 44(1):62-6. PubMed ID: 17214538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3 children with velocardiofacial (Shprintzen) syndrome].
    Lie DA; Beemer FA
    Ned Tijdschr Geneeskd; 1996 Feb; 140(7):372-5. PubMed ID: 8628424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
    Ravnan JB; Chen E; Golabi M; Lebo RV
    Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience.
    Vantrappen G; Rommel N; Devriendt K; Cremers CW; Feenstra L; Fryns JP
    Acta Otorhinolaryngol Belg; 2001; 55(1):43-8. PubMed ID: 11256191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Velo-cardio-facial syndrome: guidelines for diagnosis, treatment and follow-up of ent manifestations.
    Vantrappen G; Rommel N; Swillen A; Cremers CW; Fryns JP; Devriendt K
    Acta Otorhinolaryngol Belg; 2003; 57(2):101-6. PubMed ID: 12836465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.
    Kelly D; Goldberg R; Wilson D; Lindsay E; Carey A; Goodship J; Burn J; Cross I; Shprintzen RJ; Scambler PJ
    Am J Med Genet; 1993 Feb; 45(3):308-12. PubMed ID: 8434616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The deletions of 22q11--the Portuguese experience.
    Gaspar IM; Lourenço MT; Reis MI; Soares MA; Nogueira G; Ferreira F; Feijóo MJ
    Genet Couns; 1999; 10(1):51-7. PubMed ID: 10191429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavior and corpus callosum morphology relationships in velocardiofacial syndrome (22q11.2 deletion syndrome).
    Antshel KM; Conchelos J; Lanzetta G; Fremont W; Kates WR
    Psychiatry Res; 2005 Apr; 138(3):235-45. PubMed ID: 15854791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A bifid uvula in a patient with schizophrenia as a sign of 22q11 deletion syndrome].
    Vorstman JA; de Ranitz AG; Udink ten Cate FE; Beemer FA; Kahn RS
    Ned Tijdschr Geneeskd; 2002 Oct; 146(43):2033-6. PubMed ID: 12428463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Child with velocardiofacial syndrome and del (4)(q34.2): another critical region associated with a velocardiofacial syndrome-like phenotype.
    Tsai CH; Van Dyke DL; Feldman GL
    Am J Med Genet; 1999 Feb; 82(4):336-9. PubMed ID: 10051168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of feeding and speech disorders in 50 patients with velo-cardio-facial syndrome.
    Rommel N; Vantrappen G; Swillen A; Devriendt K; Feenstra L; Fryns JP
    Genet Couns; 1999; 10(1):71-8. PubMed ID: 10191432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a 22q11.2 deletion in cardiac patients suggests a risk for velopharyngeal incompetence.
    McDonald-McGinn DM; Driscoll DA; Emanuel BS; Goldmuntz E; Clark BJ; Solot C; Cohen M; Schultz P; LaRossa D; Randall P; Zackai EH
    Pediatrics; 1997 May; 99(5):E9. PubMed ID: 9113966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Videonasopharyngoscopy in patients with 22q11.2 deletion syndrome (Shprintzen syndrome).
    Ysunza A; Pamplona MC; Ramírez E; Canún S; Sierra MC; Silva-Rojas A
    Int J Pediatr Otorhinolaryngol; 2003 Aug; 67(8):911-5. PubMed ID: 12880672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity and specificity of endoscopy for the detection of velocardiofacial syndrome].
    Ysunza A; Pamplona M; Silva-Rojas A; Mazón JJ; Ramírez E; Canún S; Sierra Mdel C; Cervantes A
    Rev Invest Clin; 2004; 56(4):454-9. PubMed ID: 15587291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Submucous cleft palate--an often late diagnosed malformation].
    Reiter R; Haase S; Brosch S
    Laryngorhinootologie; 2010 Jan; 89(1):29-33. PubMed ID: 19644792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
    Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
    In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improvement of genetic diagnostic strategy in velo-cardio-facial syndrome].
    Pânzaru M; Rusu C; Voloşciuc M; Braha E; Butnariu L; Ivanov I; Grămescu M; Popescu R; Caba L; Sireteanu A; Macovei M; Covic M; Gorduza EV
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):756-61. PubMed ID: 22046783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.